Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NPXYY | GIB |
|---|---|---|
| Price | $17.53 | $71.06 |
| Change today | ▲ 3.85% | ▲ 1.24% |
| Market cap | $14.72B | $14.71B |
| Return, 3 months | -7.9% | +5.5% |
| Return, year to date | +19.2% | -22.6% |
| Return, 1 year | +1.6% | -21.5% |
| P/E (TTM) | 18.5 | 12.6 |
| P/B | 1.9 | 2.1 |
| P/E percentile vs own 5y | – | 8th |
| Dividend yield | 1.15% | 0.65% |
| Revenue growth (YoY, latest qtr) | – | +2.5% |
| Net profit growth (YoY) | – | +13.8% |
| Gross margin | – | 16.4% |
| Operating margin | – | 16.4% |
| Net margin | – | 10.5% |
| Return on equity | – | 17.0% |
| Analyst target vs. price | – | +10.5% |
| Analyst buy share | – | 40% |
| RSI (14) | 50 | 53 |
| 30-day volatility | 23.9% | 29.0% |
| Max drawdown, 1 year | -23.2% | -35.1% |
| Trend read | Leaning bullish | Leaning bullish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
